Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients

Clinical trial NCT06751108 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06751108
Sponsor: Seoul National University
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

NSCLC, Non Small Cell Lung Cancer

Start date: 2024-11-01
Primary completion: 2025-06-30
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.